about
Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injuryCB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in miceEndogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation.The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition.Cannabinoid receptor CB2 protects against balloon-induced neointima formation.Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes.Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages.Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke.Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways.C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes.Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice.Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice.Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis.CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion.Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice.Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury.Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis.HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.Leptin/adiponectin ratio predicts poststroke neurological outcome.Apelin-13 treatment enhances the stability of atherosclerotic plaques.Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis.Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis.Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis.Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice.Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways.Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4Corrigendum to “Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury” [J. Mol. Cell. Cardiol. 64 (2013) 99–107]Tumor necrosis factor-alpha (TNF-α) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1α) on human neutrophils through defined signalling pathwaysErratum: Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
P50
Q28298823-9C70E1D7-E1E0-4F3A-9D61-690516675B41Q34733645-5A618F8F-FA4F-4A6E-8AC0-7D3BCA47198BQ36745089-53B1F7F2-1875-4442-98BB-0E0F9EF429F8Q36754820-5E2553F9-13BB-4C41-BF39-AFD65C4A78A9Q36990311-F4FFAC7A-C983-4309-B52A-00A9F9BAC9D6Q37174735-715D468C-AC8A-4C20-9BD0-2053E7C174B2Q38753862-27835F77-D4AF-499E-9000-BD412260B00FQ40609754-FD425DBA-E3D4-464D-9370-BB24C9563B4DQ41353520-8C10D7EE-7450-4EB0-BB15-A276B5D18E9EQ41588199-F9CD31E9-3930-49E4-89A5-D9C801EBA169Q44141714-874951D4-4631-49C9-ADC4-42CD723820DEQ44590321-6D187CD4-DE46-4F78-BB77-FE9580D672E4Q44697331-DE16D842-21F2-4A44-B075-D3F115392125Q45086363-720BD463-6BCF-4213-842B-1501C4EFDE93Q46136217-97C2D070-80A7-4598-8377-13FEA5E3CB17Q46151813-CA3ADA59-9B59-46D3-923E-22BB4E6565CAQ46235885-814E5FAD-E2ED-4B17-971B-D2493F2F97EFQ46567372-25256BAA-1145-4813-9FDC-13F975D1E813Q46830410-27B7913F-1350-4681-A325-B39DD750D3DAQ46851060-59A297C2-F789-43B9-9C0C-3CD68CC5A104Q47853584-2F07388A-5793-4B4A-8B17-2217E4984CB4Q48132154-ED438449-6D1F-48BF-A5FC-97DFAD36726DQ48237646-59DC2546-DBC6-49BD-9D30-E688DBEC14B2Q48255955-C28E0831-49E5-40E9-8700-52B4615DB8FEQ50114500-94280761-7051-47F5-9B28-5D19D02EB5B6Q50159078-523EE714-F768-4C6F-80C5-176ECFC70B00Q53095336-E4711A6D-8603-4761-87BD-5B82816AD3A1Q53378752-4FBABD0F-E2E9-4F64-8622-42F671B9F9B7Q54314174-5D5940B1-EB54-46AC-B7F9-6D228DFF25E1Q55020636-02C973FB-3914-4F93-8601-5C7774D808BDQ58197550-1775E15D-FFB0-4132-9A8C-803F194BD11EQ58197585-B6D1D96A-B431-47C0-BCFE-CEB93C2C5B00Q58197684-84B0726C-4D29-4700-82F1-812455555090Q61386215-2798B0A2-6876-4431-8592-7AC9CC0DA35C
P50
name
Fabienne Burger
@ast
Fabienne Burger
@en
Fabienne Burger
@nl
type
label
Fabienne Burger
@ast
Fabienne Burger
@en
Fabienne Burger
@nl
prefLabel
Fabienne Burger
@ast
Fabienne Burger
@en
Fabienne Burger
@nl